Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Heart Failure Health Center

Font Size

FDA Approves Temporary Artificial Heart

Last Resort for Some Heart Transplant Patients
WebMD Health News

Oct. 18, 2004 -- The FDA has approved a temporary partial artificial heart intended to keep hospitalized patients alive while waiting for a heart transplant.

The device is called the CardioWest Total Artificial Heart. Made by SynCardia Systems of Tucson, Ariz., it's not intended to replace the human heart, and it's not a permanent solution.

Instead, it serves as a "bridge transplant," keeping hospitalized patients alive until donated hearts become available.

Implanted in the chest, the artificial heart replaces the bottom half of the heart and is sewn onto the top half of the patient's original heart. Tubes running through the chest wall connect to a large power-generating console, which operates and monitors the artificial heart, according to an FDA news release.

The artificial heart is expected to be used rarely.

It's seen as an option only in the most severe cases where all other approaches have failed and death is imminent within 30 days, according to news reports.

Specifically, the artificial heart is intended for heart transplant candidates with irreversible heart failure from loss of function of the lower chambers of the heart. That is, the left and right bottom quadrants of their hearts don't work.

About 4,000 people in the U.S. per year need heart transplants, but only about 100 of them might qualify for the artificial heart.

The FDA is requiring SynCardia to continue to study and monitor the device.

Prior to FDA approval, SynCardia tested the artificial heart on 81 patients at five U.S. medical centers; 79% of recipients lived long enough to receive a donor heart (an average of 79 days).

In SynCardia's study, the longest length of time a recipient lived with the device was 400 days, according to news reports.

Infection was the most common complication, affecting 72% of participants in SynCardia's study. Bleeding was seen in 42% of patients, while 25% suffered neurological events such as major or minor stroke.

The device malfunctioned in 18% of recipients, and 17 patients died before a donor heart could be found.

Organ donations don't keep pace with the demand.

Every year, about 2,200 donated hearts become available in America. That's about 1,800 fewer than what's needed, according to the FDA.

Since the new artificial heart is a temporary measure of last resort, the need for donated hearts remains as strong as ever.

Today on WebMD

Compressed heart
Salt Shockers
Inside A Heart Attack
lowering blood pressure

Mechanical Heart
Omega 3 Overview Slideshow
Atrial Fibrillation Guide
Simple Steps to Lower Cholesterol

Compressed heart
FAQ Heart Failure
Cholesterol Confusion
Health Check
Resolved To Quit Smoking